文献速递腹部MR

基于扩散峰度MRI深度学习预测直肠癌对新辅助放化疗的反应

Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
PubMed 文献 · Radiology · 2020-04-21

本前瞻性研究纳入383例局部进展期直肠腺癌患者,按时间分为训练集290例和测试集93例,构建基于扩散峰度和T2加权MRI的深度学习模型预测病理完全缓解(pCR)。测试集中pCR模型AUC为0.99,高于两位放射科医师的0.66和0.72(P均<.001);模型辅助后医师错误率降低。

要点

  • 基于扩散峰度MRI的深度学习模型预测直肠癌新辅助治疗后pCR的AUC达0.99。
  • 该模型辅助可降低放射科医师评估pCR的错误率(由26.9%和24.8%降至12.9%和14.0%)。
  • 模型预测肿瘤退缩分级(TRG)和T降期的AUC分别为0.70和0.79。

核心结论

  • 基于扩散峰度MRI的深度学习模型在预测病理完全缓解方面表现出良好性能,并有助于放射科医师评估局部进展期直肠癌新辅助放化疗后的反应。

研究设计与样本

  • 前瞻性研究,纳入经组织病理学和基线MRI证实的局部进展期直肠腺癌(≥cT3或N+)拟行术前放化疗患者,2015年10月至2017年12月入组,按时间分为308例训练样本和104例测试样本。
  • 最终共383例参与者(平均年龄57岁±10[标准差],229例男性)纳入分析,训练队列290例,测试队列93例。
  • 构建深度学习模型主要预测病理完全缓解(pCR),次要评估肿瘤退缩分级(TRG0和TRG1 vs TRG2和TRG3)和T降期;参考标准为病理结果。
  • 其他分析包括扩散峰度MRI参数比较和放射科医师主观评估。

诊断标准与关键数值

  • 测试队列中pCR模型的受试者工作特征曲线下面积(AUC)为0.99,高于评分者1和2的AUC(分别为0.66和0.72;两者P均<.001)。
  • 深度学习模型预测TRG的AUC为0.70,预测T降期的AUC为0.79。
  • 深度学习模型预测pCR的AUC优于单独使用表现最佳的扩散峰度MRI参数(新辅助治疗前校正非高斯效应后的正常扩散系数[Dapp值],AUC=0.76)。
  • 放射科医师主观评估预测pCR的错误率(1-准确率)分别为评分者1的25/93(26.9%)和评分者2的23/93(24.8%),高于深度学习模型的2/93(2.2%);在深度学习模型辅助下,评分者1和2的错误率分别降至12/93(12.9%)和13/93(14.0%)。

临床应用与阅片要点

  • 基于扩散峰度MRI的深度学习模型可能有助于放射科医师评估局部进展期直肠癌新辅助放化疗后的反应,尤其在预测pCR方面。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Preoperative response evaluation with neoadjuvant chemoradiotherapy remains a challenge in the setting of locally advanced rectal cancer. Recently, deep learning (DL) has been widely used in tumor diagnosis and treatment and has produced exciting results. Purpose To develop and validate a DL method to predict response of rectal cancer to neoadjuvant therapy based on diffusion kurtosis and T2-weighted MRI. Materials and Methods In this prospective study, participants with locally advanced rectal adenocarcinoma (≥cT3 or N+) proved at histopathology and baseline MRI who were scheduled to undergo preoperative chemoradiotherapy were enrolled from October 2015 to December 2017 and were chronologically divided into 308 training samples and 104 test samples. DL models were constructed primarily to predict pathologic complete response (pCR) and secondarily to assess tumor regression grade (TRG) (TRG0 and TRG1 vs TRG2 and TRG3) and T downstaging. Other analysis included comparisons of diffusion kurtosis MRI parameters and subjective evaluation by radiologists. Results A total of 383 participants (mean age, 57 years ± 10 [standard deviation]; 229 men) were evaluated (290 in the training cohort, 93 in the test cohort). The area under the receiver operating characteristic curve (AUC) was 0.99 for the pCR model in the test cohort, which was higher than the AUC for raters 1 and 2 (0.66 and 0.72, respectively; P < .001 for both). AUC for the DL model was 0.70 for TRG and 0.79 for T downstaging. AUC for pCR with the DL model was better than AUC for the best-performing diffusion kurtosis MRI parameters alone (diffusion coefficient in normal diffusion after correcting the non-Gaussian effect [Dapp value] before neoadjuvant therapy, AUC = 0.76). Subjective evaluation by radiologists yielded a higher error rate (1 - accuracy) (25 of 93 [26.9%] and 23 of 93 [24.8%] for raters 1 and 2, respectively) in predicting pCR than did evaluation with the DL model (two of 93 [2.2%]); the radiologists achieved a lower error rate (12 of 93 [12.9%] and 13 of 93 [14.0%] for raters 1 and 2, respectively) when assisted by the DL model. Conclusion A deep learning model based on diffusion kurtosis MRI showed good performance for predicting pathologic complete response and aided the radiologist in assessing response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Koh in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Zhang XY, Wang L, Zhu HT, et al. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. Radiology. 2020. PMID: 32315264. doi:10.1148/radiol.2020190936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。